Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | NOS1 | P29475 | 1/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.53 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.53 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.53 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.53 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.53 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.53 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9290906 | 1.00 | MEN1 (0.61) | MEN1KMT2ANOS1SIGMAR1GRIN2D | |
| SCHEMBL4575003 | 0.98 | MEN1 (0.58) | MEN1KMT2ANOS1SIGMAR1GRIN2D | |
| Iodide SCHEMBL4574651 | 0.96 | MEN1 (0.56) | MEN1KMT2ANOS1SIGMAR1GRIN2D | |
| SCHEMBL9290797 | 0.91 | — | — | |
| SCHEMBL20779515 | 0.84 | LMNA (0.55) | MEN1KMT2ANOS1SIGMAR1GRIN2D | |
| Maleic Acid SCHEMBL5151421 | 0.84 | MEN1 (0.44) | MEN1KMT2ANOS1SIGMAR1GRIN2D | |
| SCHEMBL9290971 | 0.81 | — | — | |
| SCHEMBL7041301 | 0.81 | MEN1 (0.59) | MEN1KMT2ASIGMAR1GRIN2DGRIN3B | |
| SCHEMBL6159793 | 0.81 | GRIN2D (0.62) | MEN1KMT2ASIGMAR1GRIN2DGRIN3B | |
| SCHEMBL5178061 | 0.81 | MEN1 (0.59) | MEN1KMT2ASIGMAR1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117150690-A | Pipe network layout erosion rate optimizing method and system | 中国计量大学 | 2023-12-01 | — | — | CN | disclosed |
| US-10617612-B2 | Composition comprising decanal or as active ingredients for preventing hair loss or stimulating hair growth | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2020-04-14 | — | — | US | disclosed |
| WO-2018070707-A1 | COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASE COMPRISING DECANAL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | 연세대학교 산학협력단 | 2018-04-19 | — | — | WO | disclosed |
| WO-2018070706-A1 | COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH COMPRISING DECANAL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | 연세대학교 산학협력단 | 2018-04-19 | — | — | WO | disclosed |
| US-20180104162-A1 | COMPOSITION COMPRISING DECANAL OR AS ACTIVE INGREDIENTS FOR PREVENTING HAIR LOSS OR STIMULATING HAIR GROWTH | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI U NIVERSITY (KR) | 2018-04-19 | — | — | US | disclosed |
| EP-0603160-A2 | Compositions for in-situ active compound assembly | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1994-06-22 | — | — | EP | disclosed |
| EP-0312543-A4 | _I(IN SITU) ACTIVE COMPOUND ASSEMBLY | — | 1990-12-27 | — | — | EP | disclosed |
| EP-0312543-A1 | $i(IN SITU) ACTIVE COMPOUND ASSEMBLY | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-04-26 | — | — | EP | disclosed |
| US-4812449-A | SYNTHESIS AT TARGET SITES, MICROENVIRONMENT | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-03-14 | — | — | US | disclosed |
| WO-1988000047-A1 | IN SITU ACTIVE COMPOUND ASSEMBLY | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1988-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10617612-B2 | Composition comprising decanal or as active ingredients for preventing hair loss or stimulating hair growth | TYR, CUTA, FGF1 | MEN1 865/4885KMT2A 2124/4885NOS1 1836/4885 |
| US-20180104162-A1 | COMPOSITION COMPRISING DECANAL OR AS ACTIVE INGREDIENTS FOR PREVENTING HAIR LOSS OR STIMULATING HAIR GROWTH | TYR, CUTA, FGF1 | MEN1 865/4885KMT2A 2124/4885NOS1 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.